CA2732984A1 — Process for production of bicyclo[2.2.2]octylamine derivative
Assigned to Kyorin Pharmaceutical Co Ltd · Expires 2010-02-11 · 16y expired
What this patent protects
Disclosed is a production process which can synthesize a bicyclo[2.2.2]octylamine derivative (which can be used as an intermediate for the production of a pharmaceutical agent) efficiently under mild conditions in a large quantity. The bicyclo[2.2.2]octylamine derivative can be p…
USPTO Abstract
Disclosed is a production process which can synthesize a bicyclo[2.2.2]octylamine derivative (which can be used as an intermediate for the production of a pharmaceutical agent) efficiently under mild conditions in a large quantity. The bicyclo[2.2.2]octylamine derivative can be produced by cyclizing a compound represented by general formula (1) [wherein R1 represents an alkyl group having 1 to 6 carbon atoms which may have a substituent, an arylmethyl group which may have a substituent, or an arylethyl group which may have a substituent] with a compound represented by general formula (2): R2-NH2 [wherein R2 represents an alkyl group having 1 to 6 carbon atoms which may have a substituent, an aralkyl group which may have a substituent, a hydroxy group, an alkyloxy group having 1 to 6 carbon atoms which may have a substituent, or an aralkyloxy group which may have a substituent] and reducing the resulting product.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.